Patterson Companies, Inc. (PDCO) Stock Analysis
DELISTED 2025
What happened to Patterson Companies, Inc. (PDCO) stock?
Patterson Companies, Inc. (PDCO) no longer trades on public markets. It was delisted in April 2025. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Patterson Companies, Inc. (PDCO) trades at $31.33. Patterson Companies, Inc. distributes dental and animal health products across the United States, the United Kingdom, and Canada. Market cap: $2.77B, Sector: Healthcare.
Last analyzed: May 9, 2026Analyst Coverage for PDCO: PDCO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates PDCO against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
PDCO: 1/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Patterson Companies, Inc. (PDCO) Healthcare & Pipeline Overview
Patterson Companies, Inc. is a leading distributor of dental and animal health products, offering consumables, equipment, and value-added services across North America and the UK. With a focus on practice optimization and a diverse product portfolio, Patterson serves a wide range of healthcare and animal health professionals.
What Is the Investment Thesis for PDCO?
Patterson Companies, Inc. presents a stable investment opportunity within the healthcare distribution sector. With a market capitalization of $2.77B and a P/E ratio of 15.7, the company demonstrates consistent profitability, supported by a 2.8% profit margin and a 21.0% gross margin. The company's beta of 0.72 suggests lower volatility compared to the broader market. A dividend yield of 1.66% offers a steady income stream for investors. Growth catalysts include expansion within the animal health segment and continued adoption of practice optimization solutions in the dental segment. Potential risks include competitive pressures and regulatory changes affecting the healthcare and animal health industries. The company's established distribution network and diverse product offerings provide a solid foundation for future growth.
Based on FMP financials and quantitative analysis
PDCO Key Highlights
Market capitalization of $2.77B indicates a strong market presence.
- P/E ratio of 15.7 suggests a reasonable valuation compared to earnings.
- Gross margin of 21.0% reflects efficient cost management in distribution operations.
- Dividend yield of 1.66% provides a consistent return for investors.
- Beta of 0.72 indicates lower volatility compared to the broader market, offering stability.
Who Are PDCO's Competitors?
PDCO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ONEM ONEM | $16.47 | +0.00% | $3.40B | 55 |
| AMFPF Amplifon S.p.A. | $11.21 | +0.00% | $2.97B | 38 |
| ALFRY Alfresa Holdings Corporation | $13.55 | +0.00% | $2.46B | 49 |
| PBH Prestige Consumer Healthcare Inc. | $50.52 | -2.24% | $2.39B | 64 |
| GRDN Guardian Pharmacy Services, Inc. | $37.48 | -1.29% | $2.37B | 96 |
| MEPDF MediPal Holdings Corporation | $18.35 | +0.00% | $3.76B | 49 |
| MAHLY MediPal Holdings Corporation | $18.50 | +6.51% | $3.79B | 48 |
| CAKFY McKesson Europe AG | $4.10 | +0.00% | $5.37B | 35 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are PDCO's Key Strengths?
Established distribution network
- Diverse product portfolio
- Strong customer relationships
- Private label brands
What Are PDCO's Weaknesses?
Reliance on distribution agreements
- Exposure to regulatory changes
- Competition from other distributors
- Dependence on key suppliers
What Could Drive PDCO Stock Higher?
Expansion of private label brands in the animal health segment.
- Increased adoption of practice optimization solutions in the dental segment.
- Potential strategic acquisitions to expand product portfolio.
- Geographic expansion into underserved markets.
What Are the Key Risks for PDCO?
Economic downturns affecting healthcare spending.
- Changes in healthcare regulations impacting product distribution.
- Increased competition from other distributors.
- Supply chain disruptions affecting product availability.
What Are the Growth Opportunities for PDCO?
- Expansion in Animal Health: The animal health market is experiencing growth due to increased pet ownership and rising expenditure on animal care. Patterson's Animal Health segment can capitalize on this trend by expanding its distribution network and product offerings, including private label brands like Aspen and First Companion. This segment can target a larger share of the veterinary and production animal markets, potentially increasing revenue by 10-15% over the next three years.
- Adoption of Practice Optimization Solutions: The dental segment can drive growth by promoting its practice optimization solutions, such as practice management software and e-commerce platforms. These solutions enhance efficiency and patient engagement for dental practices. With the increasing digitization of healthcare, Patterson can target a 20% increase in adoption rates among dental professionals over the next five years, boosting recurring revenue streams.
- Geographic Expansion: Patterson can explore opportunities for geographic expansion, particularly in underserved markets within North America and Europe. By establishing distribution centers and partnerships in strategic locations, the company can reach new customer segments and increase its market share. A phased expansion approach, starting with pilot programs in select regions, can mitigate risks and ensure sustainable growth.
- Strategic Acquisitions: Patterson can pursue strategic acquisitions to expand its product portfolio and market reach. Acquiring smaller distributors or specialized product manufacturers can provide access to new technologies, customer bases, and geographic markets. A disciplined approach to acquisitions, focusing on companies with complementary offerings and strong growth potential, can enhance Patterson's competitive position.
- Value-Added Services: Patterson can enhance its value proposition by offering a wider range of value-added services, such as training, consulting, and technical support. These services can strengthen customer relationships and differentiate Patterson from competitors. By providing comprehensive solutions that address the evolving needs of healthcare and animal health professionals, Patterson can increase customer loyalty and drive long-term growth.
What Are PDCO's Competitive Advantages?
- Established distribution network across the United States, the United Kingdom, and Canada.
- Diverse product portfolio in both dental and animal health segments.
- Strong relationships with healthcare professionals and animal health providers.
- Private label brands offering differentiated products.
What Does PDCO Do?
Founded in 1877 and headquartered in Saint Paul, Minnesota, Patterson Companies, Inc. has evolved from a dental supply company to a comprehensive distributor of dental and animal health products. Initially known as Patterson Dental Company, the company rebranded in 2004 to reflect its expanding business scope. Today, Patterson operates through three segments: Dental, Animal Health, and Corporate. The Dental segment provides a wide array of consumable products, including infection control, restorative materials, and instruments, as well as advanced technology and dental equipment. It also offers practice optimization solutions such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional products, consumable supplies, equipment, and software. This segment also offers value-added services and a private label portfolio under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment provides customer financing services and sells miscellaneous products. Patterson serves a diverse customer base, including dentists, laboratories, institutions, veterinarians, animal health professionals, production animal operators, and animal health product retailers across the United States, the United Kingdom, and Canada.
What Products and Services Does PDCO Offer?
- Distributes dental consumable products including infection control and restorative materials.
- Offers dental equipment and advanced technology solutions.
- Provides practice optimization software and e-commerce solutions for dental practices.
- Distributes pharmaceuticals, vaccines, and diagnostics for animal health.
- Offers private-label animal health products under the Aspen, First Companion, and Patterson Veterinary brands.
- Provides customer financing services.
How Does PDCO Make Money?
- Distributes dental and animal health products to healthcare professionals and animal health providers.
- Generates revenue through the sale of consumable products, equipment, and software.
- Offers value-added services such as software support, maintenance, and financing.
What Industry Does PDCO Operate In?
Patterson Companies, Inc. operates in the medical distribution industry, which is characterized by steady growth driven by increasing healthcare expenditure and an aging population. The competitive landscape includes companies like ONEM, which also focuses on healthcare distribution. The industry is influenced by technological advancements, regulatory changes, and supply chain dynamics. Patterson's focus on both dental and animal health provides diversification, aligning with trends in comprehensive healthcare solutions. The company's ability to adapt to evolving market demands and maintain strong relationships with healthcare providers is crucial for sustained success.
Who Are PDCO's Key Customers?
- Dentists and dental laboratories
- Veterinarians and animal health professionals
- Animal production operators
- Animal health product retailers
Company Profile
Patterson Companies, Inc. operates in the Medical - Distribution industry within the Healthcare sector. It is headquartered in Saint Paul, US. The company is led by CEO Donald J. Zurbay. PDCO has traded publicly since 1992.
How Patterson Companies, Inc. Is Valued
Patterson Companies, Inc. carries a market capitalization of $2.77B, placing it in the mid-cap category.
Key Financial Metrics
Return on equity for Patterson Companies, Inc. stands at 17.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.4%, showing how much profit it generates from its asset base. PDCO trades at a trailing price-to-earnings ratio of 15.67, below the Healthcare sector average of ~23x. Its free cash flow yield is -30.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.33 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 6.4%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Patterson Companies, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 4.10 places it in the safe zone, indicating low near-term bankruptcy risk.
Forward Outlook
Wall Street analysts project Patterson Companies, Inc. revenue of about $6.69B for fiscal 2026, with EPS near $2.20. The estimate reflects 4 contributing analysts.
PDCO Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Established distribution network
- Diverse product portfolio
- Strong customer relationships
- Private label brands
Bear Case
- Reliance on distribution agreements
- Exposure to regulatory changes
- Competition from other distributors
- Dependence on key suppliers
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
PDCO Latest News
No recent news available for PDCO.
Leadership: Donald J. Zurbay
CEO
Donald J. Zurbay serves as the Chief Executive Officer of Patterson Companies, Inc. His leadership experience and strategic vision guide the company's operations and growth initiatives. He is responsible for managing a workforce of 7600 employees, overseeing the company's diverse business segments, and driving shareholder value. His background includes extensive experience in distribution and healthcare industries.
Track Record: Under Donald J. Zurbay's leadership, Patterson Companies, Inc. has focused on expanding its market presence and enhancing its product offerings. Key milestones include strategic acquisitions and partnerships aimed at strengthening the company's competitive position. He has also overseen initiatives to improve operational efficiency and enhance customer satisfaction.
PDCO Healthcare Stock FAQ
What happened to Patterson Companies, Inc. (PDCO) stock?
Patterson Companies, Inc. (PDCO) no longer trades on public markets. It was delisted in April 2025. The figures below are historical and are not a current quote.
Can I still buy PDCO shares?
No. PDCO stopped trading on public markets in April 2025, so the shares are not available through a broker. Anything you see quoted for PDCO elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before PDCO stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Patterson Companies, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Patterson Companies, Inc. do?
Patterson Companies, Inc. is a distributor of dental and animal health products, operating through three segments: Dental, Animal Health, and Corporate. The Dental segment offers consumables, equipment, and practice optimization solutions. The Animal Health segment distributes pharmaceuticals, vaccines, and diagnostics. The Corporate segment provides customer financing services.
What do analysts say about PDCO stock?
Analyst consensus on PDCO stock reflects a neutral outlook, considering the company's stable market position and consistent profitability. Key valuation metrics, such as the P/E ratio of 15.7, suggest a reasonable valuation compared to earnings. Growth considerations include expansion in the animal health market and adoption of practice optimization solutions in the dental segment.
What are the main risks for PDCO?
The main risks for Patterson Companies, Inc. include economic downturns affecting healthcare spending, changes in healthcare regulations impacting product distribution, increased competition from other distributors, and supply chain disruptions affecting product availability. The company's reliance on distribution agreements and exposure to regulatory changes can also pose challenges.
How does Patterson Companies, Inc. navigate regulatory approval processes?
Patterson Companies, Inc. navigates regulatory approval processes by maintaining a strong compliance framework and working closely with regulatory agencies. The company ensures that its products meet all applicable regulatory requirements and standards. This includes adhering to FDA guidelines for medical devices and pharmaceuticals, as well as complying with animal health regulations.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The information provided is based on available data and may be subject to change.
- Investment decisions should be based on individual risk tolerance and financial goals.